Cost of Revenue in USD of IMMUCELL CORP /DE/ from Q3 2024 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Immucell Corp /De/ quarterly/annual Cost of Revenue history and growth rate from Q3 2024 to Q3 2025.
  • Immucell Corp /De/ Cost of Revenue for the quarter ending September 30, 2025 was $3.14M, a 29% decline year-over-year.
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Cost of Revenue, Annual (USD)

IMMUCELL CORP /DE/ Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $3.14M -$1.28M -29% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-13
Q3 2024 $4.43M Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-13

IMMUCELL CORP /DE/ Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $18.6M Jan 1, 2024 Dec 31, 2024 10-Q 2025-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.